{"id":"W3217126890","doi":"10.1200/jco.21.02229","title":"Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Cancer Foundation","funders":"National Cancer Institute; EMD Serono; Genentech; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Amgen; Celldex Therapeutics; Array BioPharma; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Melanoma; Metastatic melanoma; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001055658,0.0003277401,0.002506908,0.0002027681,0.00006481287,0.00002149181,0.0002585247,0.00043083,0.0005245098],"category_scores_gemma":[0.001077225,0.0001935427,0.0004635754,0.0004831111,0.0003786954,0.0002733536,0.00007042516,0.00118742,0.00001267167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008962182,"about_ca_system_score_gemma":0.005240915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003377469,"about_ca_topic_score_gemma":0.002304273,"domain_scores_codex":[0.9954136,0.0003884142,0.002490149,0.000433071,0.0007879325,0.0004868311],"domain_scores_gemma":[0.9949703,0.001658206,0.00169434,0.0004778527,0.0008274578,0.0003718711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3480144,0.00274259,0.5247004,0.00004475356,0.001160145,0.003079387,0.00009290258,0.0000122984,0.00002261021,0.000003168288,0.0002534264,0.1198738],"study_design_scores_gemma":[0.205177,0.05007746,0.7399107,0.0003620593,0.0004049891,0.0003112063,0.0001778579,0.000007200481,0.00007107936,0.000004206734,0.003285249,0.0002110323],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935613,0.0007283572,0.00005375833,0.00259199,0.001717326,0.0004093765,0.000007883538,0.00001859749,0.000911462],"genre_scores_gemma":[0.9933701,0.0006660518,0.002983546,0.0014752,0.0003203605,0.000009570471,0.00001932564,0.0000512925,0.001104556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2152102,"threshold_uncertainty_score":0.9297158,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07445865462662754,"score_gpt":0.4172274161971886,"score_spread":0.342768761570561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}